Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

New research uncovers how declining protein clearance mechanisms with age lead to Alzheimer’s, Parkinson’s, and other ...

AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...

Inhibikase Therapeutics is pausing work on its experimental Parkinson’s disease drug risvodetinib and seeking “strategic ...

Researchers from the Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and ...

Lucknow: New medical techniques can prove helpful in the treatment of Parkinson's disease, said experts at the ISBC ...

The findings revealed a potential link between the use of these drugs and an increased risk of Parkinson’s disease. The risk ...

Parkinson’s disease is a progressive neurodegenerative disease that destroys substantia nigra dopaminergic neurons, causing tremors, bradykinesia, rigidity, and postural instability. Current treatment ...

According to Mayo Clinic, Parkinson’s disease is a progressive disorder of the central nervous system that affects movement. The symptoms, which manifests as tremors, difficulty speaking and painful ...